Verhaltenstherapie und Psychopharmaka bei Phobien? Welche Konsequenzen hat die „Entdeckung“ der Panic-Disorder wirklich für die verhaltenstherapeutische Praxis und Forschung?

Zusammenfassung

Die Phobien stellen seit mindestens 2 Jahrzehnten einen der „klassischen“ Indikationsbereiche für Verhaltenstherapie dar. Die mittlerweile kaum noch überschaubare Literatur dazu spiegelt sowohl die glänzenden wie auch die peinlicheren Entwicklungsabschnitte dieser nicht mehr neuen und doch noch so oft mißverstandenen Therapierichtung wider.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Adler J, Hager M, Zabarsky M, Jackson T, Friendly D, Abramson P (1984) The fight to conquer fear: phobias afflict millions of americans — but new therapies are providing help. Newsweek, 23. 4. 1984Google Scholar
  2. Agras W, Chapin H, Oliveau D (1972) The natural history of phobia. Arch Gen Psychiatry 26:315–317PubMedCrossRefGoogle Scholar
  3. American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders, 2. ed. Washington D. C., American Psychiatric AssociationGoogle Scholar
  4. Appleby I, Klein D, Sachar E, Levitt M (1981) Biochemical indices of lactate induced panic: a preliminary report. In Klein D, Rabkin J (eds) Anxiety: New research and changing concepts. Raven Press, New YorkGoogle Scholar
  5. Bartling G, Fiegenbaum W, Krause R (1980) Reizüberflutung, Theorie und Praxis. Kohlhammer, Stuttgart Berlin Köln MainzGoogle Scholar
  6. Buglass D, Clarke J, Henderson A (1977) A study of agoraphobic housewifes. Psychol Med 7:73–86PubMedCrossRefGoogle Scholar
  7. Butollo W (1979) Chronische Angst, Theorie und Praxis der Konfrontationstherapie. Urban und Schwarzenberg, München WienGoogle Scholar
  8. Baltimore Cadoret R (1978) Genetic principles in the taxonomy of affective disorders. In: Akiskal H, Webb W: Psychiatric diagnosis. Spectrum publications. New YorkGoogle Scholar
  9. Caroll B (1982) Clinical applications of the dexamethasone suppression test for endogenous depression. Pharmacopsychiatrica 15:19–24CrossRefGoogle Scholar
  10. Chambless D, Goldstein A (1982) Agoraphobia. Multiple persectives on theory and treatment. Wiley, New York ChichesterGoogle Scholar
  11. Cloninger L, Martin R, Clayton P (1981) A blind follow-up and family study of anxiety neurosis: preliminary analysis of the St. Louis 500. In: Klein D, Rabkins J (eds) Anxiety: New research and changing concepts. Raven Press, New YorkGoogle Scholar
  12. Crowe R, Pauls D, Slymen D (1980) A family study of anxiety neurosis: morbidity risk in families of patients with and without mitral valve prolaps. Arch Gen Psychiatry 37:77–79PubMedCrossRefGoogle Scholar
  13. Crowe R, Noyes R, Pauls D, Slymen D (1983) A family study of panic disorder. Arch Gen Psychiatry 40:1065–1069PubMedCrossRefGoogle Scholar
  14. Curtis G, Cameron O, Nesse R (1982) The dexamethasone suppression test in panic disorder and agoraphobia. Am J Psychiatry 139:1043–1046PubMedGoogle Scholar
  15. Emmelkamp P, Kuipers A (1979) Agoraphobia: a follow-up study four years after treatment. Br J Psychiatry 134:352–355PubMedCrossRefGoogle Scholar
  16. Emmelkamp P (1982) Phobic and obsessive-compulsive disorders. Plenum Press, New YorkGoogle Scholar
  17. Errera P, Coleman J (1963) A long-term follow-up study of neurotic phobic patients in a psychiatric clinic. J Nerv Ment Dis 136:267–271CrossRefGoogle Scholar
  18. Eysenck H (1966) The effects of psychotherapy. International Science Press, New YorkGoogle Scholar
  19. Garfield E (1984) Why is the ancient and prevalent disorder called agoraphobia a neglected research topic? Current Contents 30.4.: 3–12Google Scholar
  20. Goldstein A, Chambless D (1978) A reanalysis of agoraphobia. Behav Ther 9:47–59CrossRefGoogle Scholar
  21. Gorman J, Levy G, Liebowitz M, McGrath M, Appleby I, Dillon D, Davies S, Klein D (1983) Effect of acute ß-adrenergic blockade on lactate-indured panic. Arch Gen Psychiatry 40:1079–1082PubMedCrossRefGoogle Scholar
  22. Greist J, Marks I, Berlin F, Gourney K, Noshirvani H (1980) Avoidance versus confrontation of fear. Behav Res Ther 11:1–14CrossRefGoogle Scholar
  23. Grunhaus L, Gloger S, Weisstub D (1981) Panic attacks: a review of treatments and pathogenesis. J Nerv Ment Dis 169:608–613PubMedCrossRefGoogle Scholar
  24. Hallam R (1978) Agoraphobia: a critical review of the concept. Br J Psychatry 133:314–319CrossRefGoogle Scholar
  25. Hand I (1975) Symptom-zentrierte Gruppentherapie bei Phobien — die problemorientierte Arbeitsgruppe in der Psychotherapie. Fortschr Neurol Psychiatr 43:285–304Google Scholar
  26. Hand I (1981a) Expositionsbehandlung — Implosion, flooding, exposure, Reizüberflutung. In: Linden M, Hautzinger M (Hrsg) Psychotherapie-Manual. Springer, Berlin Heidelberg New YorkGoogle Scholar
  27. Hand I (1981b) Motivationsanalyse und Motivationsmodifikation im Erstkontakt. In: Crombach-Seeger B (Hrsg) Erstkontakt — prägender Beginn einer Entwicklung. Facultas, WienGoogle Scholar
  28. Hand I (1982) Multimodale Verhaltenstherapie bei Zwängen. In: Helmchen H, Linden M, Rüger V (Hrsg) Psychotherapie in der Psychiatrie. Springer, Berlin Heidelberg New YorkGoogle Scholar
  29. Hand I (1984) Verhaltenstherapie in der Psychiatrie. Therapiewoche 34:259–270Google Scholar
  30. Hand I, Lamontagne Y (1976) The exacerbation of interpersonel problems after rapid phobia removal. Psychother Theory, Research and Practice 13:405–411CrossRefGoogle Scholar
  31. Hand I, Schröder G (1980) Die vago-vasale Ohnmacht bei der Blut-Verletzungs-Katastrophen (BVK)-Phobie. Therapiewoche 30:923–932Google Scholar
  32. Hand I, Zaworka W (1982) An operationalized multisymptomatic model of neuroses (OMMON): Towards a reintegration of diagnosis and treatment in behaviour therapy. Arch Psychiatr Nervenkr 232:359–379PubMedCrossRefGoogle Scholar
  33. Hand I, Lamontagne Y, Marks I (1974) Group exposure (flooding) in vivo for agoraphobics. Br J Psychiatry 124:588–602PubMedCrossRefGoogle Scholar
  34. Hand I, Spoehring B, Stanik E (1977) Treatment of obsessions, compulsions and phobias as hidden couple counseling. In: Boulougouris J, Rabavilas A (eds): Phobic and obsessive compulsive disorders. Pergamon Press, New YorkGoogle Scholar
  35. Harris E, Noyes R, Crowe R, Chaudhry O (1983) Family study of agoraphobia. Arch Gen Psychiatry 40:1061–1064PubMedCrossRefGoogle Scholar
  36. Jacob R, Moller M, Turner S, Wall C (1983) Otoneurological dysfunction in patients with panic disorder or agoraphobia with panic attacks. Vortrag u. Manuskript zum World Congress on Behavior Therapy, Washington, 8.-11. 12. 1983Google Scholar
  37. Jannoun L, Munby M, Catalan J, Gelder M (1980) A home-based treatment program for agoraphobia: replication and controlled evaluation. Behav Res Ther 11:294–305CrossRefGoogle Scholar
  38. Jansson L, Ost C (1982) Behavioral treatment for agoraphobia: an evaluative review. Clin Psychol Rev 2:311–336CrossRefGoogle Scholar
  39. Kanfer F, Grimm L (1980) Managing clinical change: a process model of theory. Behav Modification 4:419–444CrossRefGoogle Scholar
  40. Kantor J, Zitrin C, Zeldis S (1980) Mitral valve prolapse syndrom in agoraphobic patients. Am J Psychiatry 137:4Google Scholar
  41. Kelly D, Mitchell-Heggs N, Sherman D (1971) Anxiety and the effects of sodium lactate assessed clinically and physiologically. Br J Psychiatry 119:468–470CrossRefGoogle Scholar
  42. Klein D (1981) Anxiety reconceptualized. In: Klein D, Rabkin J (eds) Anxiety: New research and changing concepts. Raven Press, New YorkGoogle Scholar
  43. Klein D (1983a) Panic and anxiety: in reply. Arch Gen Psychiatry 40:1149CrossRefGoogle Scholar
  44. Klein D (1983b) Panic attacks in phobia: treatment studies. in reply. Arch Gen Psychiatry 40:1151CrossRefGoogle Scholar
  45. Klein D, Fink M (1962) Psychiatric reaction patterns to Imipramine. Am J Psychiatry 119:432–438PubMedGoogle Scholar
  46. Klein D, Ross D, Woerner M, Zitrin C (1983b) Phobia study criteria — in reply. Arch Gen Psychiatry 40:1150CrossRefGoogle Scholar
  47. Klein D, Zitrin C, Woerner M, Ross D (1983a) Treatment of phobia II. Behavior therapy and supportive psychotherapy — are there any specific ingredients. Arch Gen Psychiatry 40:139–145PubMedCrossRefGoogle Scholar
  48. Laughren T, Battey Y, Greenblatt D et al. (1982) A controlled trial of diazepam withdrawal in chronically anxious outpatients. Acta Psychiatr Scand 65:171–179PubMedCrossRefGoogle Scholar
  49. Leckman J, Weissman M, Merikangas K, Pauls D, Prusoff B (1983a) Panic disorder and major depression. Arch Gen Psychiatry 40:1055–1060PubMedCrossRefGoogle Scholar
  50. Leckman J, Merikangas K, Pauls D, Prusoff B, Weissman M (1983b) Anxiety disorders and depression: contradictions between family study data and DSM-III conventions. Am J Psychiatry 140:880–882PubMedGoogle Scholar
  51. Lieberman J, Brenner R, Lesser M, Coccaro E, Borenstein M, Kane J (1983) Dexamethasone suppression tests in patients with panic disorder. Am J Psychiatry 140:917–919PubMedGoogle Scholar
  52. Liebowitz M, Klein D (1982) Agoraphobia: clinical features, patho-physiology, and treatment. In Chambless D, Goldstein A (eds) Agoraphobia: multiple perspectives on theory and treatment. Wiley, New YorkGoogle Scholar
  53. Marks I (1969) Fears and Phobias. Weidenfeld, LondonGoogle Scholar
  54. Marks I (1970) The classification of phobic disorders. Br J Psychiatry 116:337–380CrossRefGoogle Scholar
  55. Marks I (1975) Behavioral treatments of phobic and obsessive-compulsive disorders: a critical appraisal. In: Hersen M, Eisler R, Miller P (eds) Progress in behavior modification. Academic Press, New YorkGoogle Scholar
  56. Marks I (1977) Bewältigung der Angst. Springer, Berlin Heidelberg New YorkGoogle Scholar
  57. Marks I (1981) Cure and care of neuroses. John Wiley & sons, New YorkGoogle Scholar
  58. Marks I (1983a) Phobia study criteria. Arch Gen Psychiatry 40:1150CrossRefGoogle Scholar
  59. Marks I (1983b) Panic attacks in phobia: treatment studies. Arch Gen Psychiatry 40:1151CrossRefGoogle Scholar
  60. Marks I (1983c) Are there anticompulsive or antiphobic drugs? Review of the evidence. Brit J Psychiatry 143:338–347CrossRefGoogle Scholar
  61. Marks I, Gray S, Cohen D, Hill R, Mawson D, Ramm E, Stern R (1983) Imipramine and brief therapist-aided exposure in agoraphobics having self-exposure homework. Arch Gen Psychiatry 40:153–162PubMedCrossRefGoogle Scholar
  62. Mathews A, Gelder M, Johnston D (1981) Agoraphobia. Nature and treatment. Guildford Press, New YorkGoogle Scholar
  63. Matuzas W, Glass R (1983) Treatment of agoraphobia and panic attacks. Arch Gen Psychiatry 40:220–222PubMedCrossRefGoogle Scholar
  64. Mavissakalian M (1982) Pharmacologic treatment of anxiety disorder. J Clin Psychiat 43:487–491Google Scholar
  65. Mavissakalian M, Michelson L, Dealy S (1983) Pharmacological treatment of agoraphobia: Imipramine versus Imipramine with programmed practice. Br J Psychiatry 143:348–355PubMedCrossRefGoogle Scholar
  66. McDonald R, Sartory G, Grey S, Cobb J, Stern R, Marks I (1979) The effects of self-exposure instructions on agoraphobic outpatients. Behav Res Ther 17:1183–1185CrossRefGoogle Scholar
  67. McNair D, Kahn R (1981) Imipramine compared with benzodiazepine for agoraphobia. In: Klein D, Rabkin J (eds) Anxiety: New Research and changing concepts. Raven Press, New York: pp 69–79Google Scholar
  68. Munjak D, Moss H (1981) Affective disorder and alcoholism in families of agoraphobics. Arch Gen Psychiatry 38:869–871CrossRefGoogle Scholar
  69. Noyes R, Clancy J, Crowe R (1978) The familial prevalence of anxiety neurosis. Arch Gen Psychiatry 35:1057–1059PubMedCrossRefGoogle Scholar
  70. Noyes R (1982) Beta-blocking drugs and anxiety. Psychosomatics 23:155–170PubMedGoogle Scholar
  71. Noyes R, Anderson D, Clancy J, Crowe R, Slyman D. Ghoneim M, Hinrichs J (1984) Diazepam and propanolol in panic disorder and agoraphobia. Arch Gen Psychiatry 41:287–292PubMedCrossRefGoogle Scholar
  72. Öst L, Hugdahl K (1981) Acquisition of phobias and anxiety response patterns in clinical patients. Behav Res Ther 19:439–447PubMedCrossRefGoogle Scholar
  73. Öst L, Hugdahl K (1983) Acquisition of agroaphobia, mode of onset and anxiety response patterns. Behv Res Ther 21:623–631CrossRefGoogle Scholar
  74. Pariser S, Pinta E, Jones B (1978) Mitral valve prolaps syndrome and anxiety neurosis/panic disorder. Am J Psychiatry 134:246–247Google Scholar
  75. Petursson H, Lader M (1981) Withdrawal from long-term benzodiazepine treatment. Br Med J 283:643–645CrossRefGoogle Scholar
  76. Rachman S (1984) Agoraphobia — a safety signal perspective. Behav Res Ther 22:59–70PubMedCrossRefGoogle Scholar
  77. Raskin M, Peeke H, Dickman W et al. (1982) Panic and generalized anxiety disorders: developmental antecedants and précipitants. Arch Gen Psychiatry 39:687–689PubMedCrossRefGoogle Scholar
  78. Sheehan D, Ballenger J, Jacobsen G (1980) Treatment of endogenous anxiety with phobic hysterical, and hypochondrical symptoms. Arch Gen Psychiatry 37:51–59PubMedCrossRefGoogle Scholar
  79. Sheehan D, Claycomb J, Surman O, Baer L, Coleman J, Gelles L (1983) Panic attacks and the Dexamethasone suppression test. Am J Psychiatry 140:1063–1064PubMedGoogle Scholar
  80. Snaith R (1983) Phobia study criteria. Arch Gen Psychiatry 40:1149–1150PubMedCrossRefGoogle Scholar
  81. Solyom C, Solyom L, LaPievre Y, Pecknold J, Morton L (1981) Phenelzine and exposure in the treatment of phobias. Biol Psychiatry 3:239–247Google Scholar
  82. Telch M, Teaman B, Taylor C (1983) Antidepressant medication in the treatment of agoraphobia. Behav Res Ther 21:505–517PubMedCrossRefGoogle Scholar
  83. Thorpe G, Burns L (1983) The Agoraphobic Syndrome. Wiley, New York ChichesterGoogle Scholar
  84. Torgersen S (1983) Genetic factors in anxiety disorders. Arch Gen Psychiatry 40:1085–1089PubMedCrossRefGoogle Scholar
  85. Tyrer P (1984) Classification of anxiety. Br J Psychiatry 144:78–83PubMedCrossRefGoogle Scholar
  86. Tyrer P, Lader M (1974) Response to propranolol and diazepam in somatic anxiety. Br Med J 2:14–16PubMedCrossRefGoogle Scholar
  87. Tyrer P, Rutherford D, Huggett T (1981) Benzodiazepine withdrawal symptoms and propranolol. Lacnet 1:520Google Scholar
  88. Wilson G (1982) Fear reduction methods and the treatment of anxiety disorders. In: Franks C, Wilson G, Kendall P, Brownell K: Annual Review of Behavior Therapy. Vol. 8 Guildford Press, New YorkGoogle Scholar
  89. Wölpe J (1958) Psychotherapy by reciprocal inhibition. Stanford University Press, StanfordGoogle Scholar
  90. Zitrin C, Klein D, Woerner M (1980) Treatment of agoraphobia with group exposure in vivo and Imipramine. Arch Gen Psychiatry 37:63–72PubMedCrossRefGoogle Scholar
  91. Zitrin C, Klein D, Woerner M, Ross D (1983) Treatment of phobias: I. comparison of Imipramine hydrochloride and placebo. Arch Gen Psychiatry 40:125–138PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1984

Authors and Affiliations

  • I. Hand

There are no affiliations available

Personalised recommendations